Real-World Clinical Experience of Semaglutide in Secondary Care Diabetes: A Retrospective Observational Study.

David M WilliamsAliya M RuslanRahim KhanDaneeshanan VijayasingamFizzah IqbalAyesha ShaikhJia LimRichard ChudleighRajesh PeterManeesh UdiawarStephen C BainJeffrey W StephensThinzar Min

Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2021)

Semaglutide provided clinically and statistically significant reductions in HbA1c, body weight, lipids and liver enzymes.

Keyphrases

body weight
type diabetes
healthcare
palliative care
cardiovascular disease
quality improvement
glycemic control
pain management
affordable care act
adipose tissue
insulin resistance